CTTI

150+ leaders. 1 big goal: transform #clinicaltrials.

#CTTI’s inaugural #StateOfClinicalTrials meeting tackled the toughest barriers to change—and sparked bold, actionable ideas.

🔗 Dive into the recap: Inside the State of Clinical Trials bit.ly/SOCT

#CTTI recently launched two new resources to help clinical research teams apply Quality by Design (QbD) principles throughout trial design and development.

➡️ Learn more: ow.ly/JqIi51024s1

As clinical development efficiency continues to evolve, understanding how expedited programs are used in practice is increasingly important. CTTI’s EEP booklet provides a foundation for considering lessons learned from these pathways.

Explore the booklet: ow.ly/yBB650ZHiW6

Read now in the Journal of Clinical & Translational Science: #CTTI provides recommendations to support the broader use of disease progression modeling (DPM) in medical product development. 🔗ow.ly/kRU450Zx3ch

AI is already being used across drug and biological product development — but what will it take to ensure its use is responsible, transparent, and fit for purpose?

🔗 Explore key insights from the most recent FDA/CTTI Public Workshop: ow.ly/LHFb50Znow0